Tuesday, June 18, 2024
AEYE Health and Optomed are excited to announce the launch of Aurora AEYE, the first-ever portable, fully autonomous screening solution for diabetic retinopathy.
This innovative device allows for screenings to be conducted anywhere, including at home or in clinics, with immediate diagnostic results provided without the need for human interpretation.
Aurora AEYE will be unveiled at the American Diabetes Association's 84th Scientific Session in Orlando, FL. Attendees can visit booths 506 and 512 to see and try the product.
As the first FDA-cleared solution of its kind, Aurora AEYE requires only one image per eye and delivers instant results directly on the camera screen for patients, along with comprehensive diagnostic reports for healthcare providers.
Its portable, internet-connected design facilitates screenings in clinics, at patient bedsides, and at home. This device aims to revolutionize diabetic retinopathy screening by increasing accessibility and efficiency, ultimately enhancing patient outcomes and promoting global health equity.
The system simplifies insurance reporting and care gap closure with automatically generated diagnostic reports. It facilitates reimbursement through a dedicated AI CPT code 92229 for autonomous screening, which significantly improves accessibility. Additionally, it supports HEDIS measures and contributes to star ratings for many health plans.
Diabetic retinopathy affects 85% of diabetic patients over 40 and is the leading cause of vision loss in working-age adults. Approximately 40 million people in the U.S. and over 500 million worldwide are at risk.
Despite the potential for prevention through early detection, many people with diabetes face challenges in accessing annual eye exams.
"The launch of Aurora AEYE represents a major advancement in the fight against diabetic retinopathy."
"By incorporating FDA-grade AI into a portable camera, we are democratizing early detection, making it more accessible and affordable for millions worldwide and removing barriers to traditional healthcare."
"We are thrilled to partner with AEYE Health to bring this groundbreaking technology to market."
"Aurora AEYE combines our advanced portable retinal cameras with AEYE's autonomous AI diagnostics, providing a powerful tool for healthcare providers.
This innovation addresses the critical need for more accessible diabetic retinopathy screenings, especially in remote and home care settings."
Source: prnewswire.com
